drugset / Trial / NCT04345471
A Study of MD-120 in Patients With Depression
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to verify the efficacy and evaluate the safety of 8-week once-daily oral administration of MD-120 in Japanese patients with depression.
Timeline
- Start
- 2020-05-18
- Primary completion
- 2022-07-21
- Completion
- 2022-09-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desvenlafaxine | Other / unclassified | 50 mg | Oral |
| Subject | Desvenlafaxine | Other / unclassified | 100 mg | Oral |